| Business Summary | | Packard
BioScience
Company
develops,
manufactures
and
markets
instruments
and
related
consumables
and
services
for
use
in
drug
discovery
and
other
life
sciences
research.
The
Company's
products
are
intended
to
meet
the
experimentation
needs
of
a
diverse
customer
base,
including
pharmaceutical,
biotechnology,
agricultural
and
diagnostics
companies.
The
Company
is
primarily
focused
on
integrating
its
products
to
form
platforms
in
the
areas
of
drug
screening,
the
process
of
testing
vast
libraries
of
different
compounds
in
relatively
simple
tests,
known
as
assays,
containing
biological
molecules,
called
targets,
which
are
believed
to
have
a
significant
role
in
the
onset
or
development
of
a
disease;
functional
genomics,
the
analysis
of
gene
variations
and
function
and
their
association
with
specific
diseases;
and
proteomics,
the
study
of
the
function
of
genes
by
direct
analysis
of
the
proteins
produced
by
such
genes
for
the
identification
and
validation
of
targets. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Packard
BioScience
is
a
developer,
manufacturer
and
marketer
of
instruments
and
related
consumables
and
services
for
use
in
the
life
sciences
research
and
nuclear
industries.
For
the
six
months
eneded
6/30/01,
revenues
rose
28%
to
$100.5
million.
Net
income
from
cont'd.
operations
before
extraordinary
items
totaled
$1.7
million
vs.
a
loss
of
$3.9
million.
Results
reflect
the
acquisition
of
the
Life
Sciences
division
of
GSI
Lumonics
and
decreased
interest
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Emery Olcott, 62 Chairman,
CEO | $656K | $466K | Franklin Witney, Ph.D., 47 Pres
and COO and Pres of Packard Instruments Company | 309K | -- | Ben Kaplan, 43 VP,
CFO | 344K | -- | Timothy White, Jr., 33 VP,
Gen. Counsel, Sec. | -- | -- | Staf Van Cauter, 52 VP-Bus.
Devel. | 289K | 686K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|